LENZ
LENZ Therapeutics
LENZ
LENZ
160 hedge funds and large institutions have $562M invested in LENZ Therapeutics in 2025 Q4 according to their latest regulatory filings, with 50 funds opening new positions, 53 increasing their positions, 33 reducing their positions, and 56 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
48% less call options, than puts
Call options by funds: $2.74M | Put options by funds: $5.28M
59% less capital invested
Capital invested by funds: $1.36B → $562M (-$794M)
67% less funds holding in top 10
Funds holding in top 10: 9 → 3 (-6)
Holders
160
Holding in Top 10
3
Calls
$2.74M
Puts
$5.28M
Top Buyers
| 1 | +$105M | |
| 2 | +$22.5M | |
| 3 | +$16.6M | |
| 4 |
Millennium Management
New York
|
+$15.7M |
| 5 |
Franklin Resources
San Mateo,
California
|
+$14.8M |
Top Sellers
| 1 | -$50M | |
| 2 | -$40.2M | |
| 3 | -$32.3M | |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
-$29.2M |
| 5 |
SVCM
Saturn V Capital Management
Austin,
Texas
|
-$17.1M |
